Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V E Allgood

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Steroids|July 1, 1994
Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoidC M Silva, F E Powell-Oliver, C M Jewell, et al.
British Journal of Cancer|April 27, 2016
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumoursD Mahalingam, G Wilding, S Denmeade, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Steroids|July 1, 1994
Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoidC M Silva, F E Powell-Oliver, C M Jewell, et al.
British Journal of Cancer|April 27, 2016
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumoursD Mahalingam, G Wilding, S Denmeade, et al.
Pageof 2